Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting
Sign Up to like & getrecommendations! Published in 2018 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-018-5319-6
Abstract: BackgroundInfliximab is a chimeric anti-tumor necrosis factor alpha (TNF-α) monoclonal antibody that ameliorates inflammation when it binds to and neutralizes TNF-α. It is often used in patients with Crohn’s disease and ulcerative colitis to reduce… read more here.
Keywords: incidence; infusion; infusion reactions; care setting ... See more keywords
Assessment of cetuximab-induced infusion reactions and administration rechallenge at an academic medical center
Sign Up to like & getrecommendations! Published in 2017 at "Medical Oncology"
DOI: 10.1007/s12032-017-0902-9
Abstract: Cetuximab is approved for treatment of squamous cell carcinoma of the head and neck (SCCHN). Cetuximab is generally well tolerated, but does carry a black box warning for infusion reactions (IRs). Incidence of IR in… read more here.
Keywords: incidence; infusion reactions; assessment cetuximab; cetuximab ... See more keywords
1144. Rate of Infusion Reactions Among Patients Receiving Casirivimab/Imdevimab in the Home Setting
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac492.982
Abstract: Abstract Background Monoclonal antibodies used in the treatment and prevention of COVID 19 infection are an emerging area of infectious disease. Casirivimab/imdevimab received emergency use authorization (EUA) for the prophylaxis and treatment of COVID 19… read more here.
Keywords: infusion reactions; infusion time; casirivimab imdevimab; rate ... See more keywords
SAT0486 SERIOUS ADVERSE EVENTS OF TOCILIZUMAB IN CHILDREN WITH RHEUMATIC DISEASES – A REAL-WORLD EXPERIENCE
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.5311
Abstract: Background Tocilizumab (TCZ) is a humanized monoclonal antibody that blocks interleukin 6. In children, TCZ has been approved for the treatment of systemic-onset and polyarticular course juvenile idiopathic arthritis (JIA), and is used off-label in… read more here.
Keywords: tcz; infusion; treatment; adverse events ... See more keywords
The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.526
Abstract: 526 Background: Infusion reactions have been reported in studies of metastatic colorectal cancer (mCRC) patients treated with anti-EGFR therapies, including cetuximab and panitumumab, with incidences ranging from 0-33%. A systematic literature review and meta-analysis were… read more here.
Keywords: infusion; incidence infusion; infusion reactions; meta analysis ... See more keywords
Effectiveness of scheduled vital signs assessment during infliximab infusions in detecting infusion reactions: a multi-centre retrospective data review.
Sign Up to like & getrecommendations! Published in 2022 at "British journal of nursing"
DOI: 10.12968/bjon.2022.31.2.s16
Abstract: PURPOSE To determine if scheduled vital signs monitoring is useful in the detection of infusion reactions to infliximab (IFX). METHODS The infusion records of 35,988 IFX infusions completed in 2017 were reviewed for infusion reactions… read more here.
Keywords: vital signs; infusion; signs assessment; scheduled vital ... See more keywords